Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Cholangiocarcinoma 1

Interventions

pembrolizumab 213Cyclophosphamide 123Nivolumab 110Carboplatin 94fludarabine 81Gemcitabine 78Specimen Handling 74Bevacizumab 73Injections 71venetoclax 70Magnetic Resonance Spectroscopy 67Dexamethasone 66Paclitaxel 64Biopsy 59atezolizumab 57Cisplatin 54Ipilimumab 50Temozolomide 46Lenalidomide 43Azacitidine 43Docetaxel 42Pemetrexed 41Rituximab 40Radiotherapy 40Oxaliplatin 40Fluorouracil 39Cetuximab 38durvalumab 37Cytarabine 36Capecitabine 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × DEAE-Dextran × 1 year × Clear all
NCT07595172 2026-05-19

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

West China Hospital

Phase 1/2 Recruiting
55 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07291947 2025-12-18

PULSAR Combined With Immunotherapy and Chemotherapy

West China Hospital

Phase 1/2 Recruiting
60 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡